Professor Arnie Purushotham
Professor of Breast Cancer
Research interests
- Cancer
- Women
Contact details
Biography
Professor Arnie Purushotham has been a Consultant Academic Surgeon for 26 years having worked in Glasgow, Cambridge, and London. He is a Professor of Breast Cancer at King’s and Consultant Surgeon at Guy’s and St Thomas NHS Foundation Trust. He is also the Director of King’s Health Partners Comprehensive Cancer Centre.
As a scientific researcher, Professor Purushotham’s goal has been to drive high-quality clinical and translational research that directly impacts patients with cancer. Key areas of research are patterns of metastatic spread, novel optical intra-operative imaging, MR Elastography to predict response or resistance to neoadjuvant chemotherapy, window of opportunity trials, prevention, and early detection, cancer in low- and middle-income countries, and cancer outcomes.
Research
Institute of Cancer Policy
The Institute of Cancer Policy brings together global cancer faculty across King’s College London and it’s NHS partner hospitals under Kings’ Health Partners.
Cancer Biology
Cancer Biology
News
2023 Surgery Commission offers solutions to improve cancer surgery outcomes
King’s academics have collaborated with researchers, doctors and surgeons to make eight recommendations to help improve cancer surgery outcomes across the...
Higher risk of cancer following 'all clear' after suspected cancer referral
Patients who were referred to urgent suspected cancer pathways, but were found not to have cancer at that time, have a higher risk of subsequent cancer in the...
Experimental cancer treatments receive funding boost
King's Health Partners (KHP) Experimental Cancer Medicine Centre (ECMC) has had its funding renewed for the next five years.
Research
Institute of Cancer Policy
The Institute of Cancer Policy brings together global cancer faculty across King’s College London and it’s NHS partner hospitals under Kings’ Health Partners.
Cancer Biology
Cancer Biology
News
2023 Surgery Commission offers solutions to improve cancer surgery outcomes
King’s academics have collaborated with researchers, doctors and surgeons to make eight recommendations to help improve cancer surgery outcomes across the...
Higher risk of cancer following 'all clear' after suspected cancer referral
Patients who were referred to urgent suspected cancer pathways, but were found not to have cancer at that time, have a higher risk of subsequent cancer in the...
Experimental cancer treatments receive funding boost
King's Health Partners (KHP) Experimental Cancer Medicine Centre (ECMC) has had its funding renewed for the next five years.